135 related articles for article (PubMed ID: 149657)
21. Circular dichroism studies on alpha 2-antiplasmin and its interactions with plasmin and plasminogen.
Nilsson T; Sjöholm I; Wiman B
Biochim Biophys Acta; 1982 Jul; 705(2):264-70. PubMed ID: 6214280
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the antiplasmin activity of human thrombospondin-1 in solution.
Anonick PK; Yoo JK; Webb DJ; Gonias SL
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):903-9. PubMed ID: 7679575
[TBL] [Abstract][Full Text] [Related]
23. Kinetics of the inhibition of plasmin in acidified human plasma.
Lijnen HR; Maes M; Castel M; Samama M; Collen D
Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
[TBL] [Abstract][Full Text] [Related]
24. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
Petersen LC; Suenson E
Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
[TBL] [Abstract][Full Text] [Related]
25. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
26. Differences between neonates and adults in carbohydrate sequences and reaction kinetics of plasmin and alpha(2)-antiplasmin.
Ries M; Easton RL; Longstaff C; Zenker M; Morris HR; Dell A; Gaffney PJ
Thromb Res; 2002 Feb; 105(3):247-56. PubMed ID: 11927131
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of plasmin inhibition in the presence of a synthetic tripeptide substrate. The reaction with pancreatic trypsin inhibitor and two forms of alpha 2-plasmin inhibitor.
Petersen LC; Clemmensen I
Biochem J; 1981 Oct; 199(1):121-7. PubMed ID: 6175313
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the murine plasma fibrinolytic system.
Lijnen HR; van Hoef B; Beelen V; Collen D
Eur J Biochem; 1994 Sep; 224(3):863-71. PubMed ID: 7523120
[TBL] [Abstract][Full Text] [Related]
29. The role of alpha 2-antiplasmin in the inhibition of clot lysis in newborns and adults.
Ries M; Klinge J; Rauch R; Keuper H; Harms D
Biol Neonate; 1996; 69(5):298-306. PubMed ID: 8790908
[TBL] [Abstract][Full Text] [Related]
30. A monoclonal antibody directed against the high-affinity lysine-binding site (LBS) of human plasminogen. Role of LBS in the regulation of fibrinolysis.
Holvoet P; Lijnen HR; Collen D
Eur J Biochem; 1986 May; 157(1):65-9. PubMed ID: 2940088
[TBL] [Abstract][Full Text] [Related]
31. Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.
Stephens RW; Pöllänen J; Tapiovaara H; Leung KC; Sim PS; Salonen EM; Rønne E; Behrendt N; Danø K; Vaheri A
J Cell Biol; 1989 May; 108(5):1987-95. PubMed ID: 2523891
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
Lijnen HR; De Cock F; Collen D
Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
[TBL] [Abstract][Full Text] [Related]
33. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the interaction between plasminogen and staphylokinase.
Lijnen HR; De Cock F; Van Hoef B; Schlott B; Collen D
Eur J Biochem; 1994 Aug; 224(1):143-9. PubMed ID: 8076635
[TBL] [Abstract][Full Text] [Related]
35. On the molecular interactions between plasminogen-staphylokinase, alpha 2-antiplasmin and fibrin.
Lijnen HR; Van Hoef B; Matsuo O; Collen D
Biochim Biophys Acta; 1992 Jan; 1118(2):144-8. PubMed ID: 1730031
[TBL] [Abstract][Full Text] [Related]
36. Binding site of alpha 2-plasmin inhibitor to plasminogen.
Sugiyama N; Sasaki T; Iwamoto M; Abiko Y
Biochim Biophys Acta; 1988 Jan; 952(1):1-7. PubMed ID: 3334852
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen-plasmin system IX. Specific binding of tranexamic acid to plasmin.
Iwamoto M
Thromb Diath Haemorrh; 1975 Jun; 33(3):573-85. PubMed ID: 125463
[TBL] [Abstract][Full Text] [Related]
38. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
39. Plasmin-mediated fibrinolysis by variant recombinant tissue plasminogen activators.
Urano S; Metzger AR; Castellino FJ
Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2568-71. PubMed ID: 2523073
[TBL] [Abstract][Full Text] [Related]
40. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
